Melody S.

About Melody S.

With 24 years leading global biopharmaceutical operations — from greenfield facility development to enterprise-wide transformation — I’ve built supply chain capabilities that deliver measurable P&L impact. My approach treats IBP not as a planning process, but as the operating system that connects commercial strategy, financial planning, and operational execution: Architected S & OP/IBP foundations for a $1B+ greenfield biologics manufacturing facility, integrating capacity, materials, procurement, and production into a unified decision-making framework Led global inventory optimization initiatives delivering $20M+ in documented savings across manufacturing sites in the U.S, Switzerland, and Denmark Directed SAP E2E implementation defining enterprise data architecture, planning models, and analytics capabilities that enable scenario-based decision making Built and scaled supply chain organizations from inception — hiring, developing, and leading cross-functional teams of 40+ professionals with full P&L accountability Successfully relocated GMP Cell Banks across multiple sites with zero supply disruptions — a mission-critical regulatory initiative :I believe the best supply chain leaders think like CFOs and operate like COOs. Every planning decision should connect to margin, cash flow, and competitive advantage. I build teams that balance analytical rigor with operational pragmatism — and cultures where cross-functional collaboration isn’t aspirational, it’s how we work.Currently, I’m building supply chain capabilities for Amgen’s strategic greenfield biologics facility while serving as Chair of ISPE’s Women in Pharma International Steering Committee — advocating for the next generation of pharma operations leaders:Integrated Business Planning (IBP) • S & OP Design & Implementation • Enterprise Supply Chain Strategy • Demand & Supply Planning • Materials Management • SAP/ERP Implementation • Digital Transformation • Greenfield Operations • GMP/Regulatory Compliance • Biologics & Biopharma Manufacturing • Lean Six Sigma • Organizational Development’ :I’m always open to conversations about supply chain transformation, IBP best practices, and the future of biopharma operations. Whether you’re navigating a greenfield launch, scaling IBP capabilities, or building high-performing planning teams — let’s talk.Open to connecting — send me a message.

Experience

1. Director Supply Chain

   Amgen

   May 2022 — Present · US

Education

• Duke University - The Fuqua School of Business

  MBA, Business

  2008 — 2009

• Virginia Tech

  BS, Chemical Engineering

  1995 — 1999

• North Carolina State University

  M.S., Chemical Engineering

  1999 — 2001